About PharmEvo

pharmevo.biz

PharmEvo is a pharmaceutical company that develops, manufactures, and markets healthcare solutions.

Revenue : 100M-200M Industry : Pharmaceuticals Location : Pakistan Employees : 1000-5000

SaaS Adoption

SaaS Adoption indicates the level of adoption by this company of software as a service services.

Cloud Adoption

Cloud Adoption indicates the level of adoption by this company of cloud services.

IT Footprint

IT Footprint gives a relative indication of how much IT services this company consumes.

IT Spend

IT Spend shows roughly how much this client spends on IT per year in USD.

Enlyft tracks the use of over 15,000 technologies and has proprietary data on over 18 million companies worldwide.

Know the products your prospects use

Enlyft provides you with access to our real-time data platform where you can access insights into a company’s tech stack, firmographic data, and more.

Vendor Usage

PharmEvo uses 5 different technologies from 21 different vendors. They have above average use of several technologies including WooCommerce, Salesforce.com CRM and Rackspace Mailgun.

Product Categories

PharmEvo uses products from 19 different product categories. They are particularly heavy users of products in Enterprise Resource Planning (ERP), Cloud Platforms & Services, and Software Frameworks.

Recently Detected Technologies

Enlyft tracks the use of over 15,000 technologies and has proprietary data on over 18 million companies worldwide.

Technology Category Vendor Usage
WooCommerce eCommerce Automattic
Salesforce.com CRM Customer Relationship Management (CRM) Salesforce.com, inc
SAP S/4HANA Enterprise Resource Planning (ERP) SAP
SAP ERP Enterprise Resource Planning (ERP) SAP
SAP HANA Database Management System SAP

Are you interested in knowing other companies with similar tech stacks?

Reveal what vendors your prospects are using

Enlyft Sales Insights gives you instant access to the tech stack and firmographics of millions of companies worldwide.
Logos provided by Clearbit

© Enlyft | All rights reserved.